Cancer Control

Edited by J. Mark Elwood and Simon B. Sutcliffe

Addresses an important population health concern with substantial medical and socio-economic impact
Comprehensive across aspects of population health, medical practice, clinical care and well-being
Incorporates issues related to quality of life, patient and public engagement, palliation and ethics
Acknowledges contextual realities and differences between resource settings in relation to cancer control programme
Written for a general audience, so no previous knowledge of the topic is assumed

Cancer Control

Edited by J. Mark Elwood and Simon B. Sutcliffe

Description

Cancer control is the term applied to the development of integrated population-based approaches to reduce the incidence and mortality from cancer and to minimize its impact on affected individuals and on the community. It covers a spectrum of prevention, early diagnosis, optimal treatment, and supportive and palliative care. It emphasizes the application of new knowledge gained through research to achieve current best practice. Cancer control has become a political priority in many countries in recent years, with the evolution of both national and regional cancer control strategic plans. The integrated nature of cancer control, involving a wide spectrum of health care professionals, researchers, and health managers and planners, is reflected in this multi-disciplinary text, which is the first in this rapidly developing field.

Cancer Control

Edited by J. Mark Elwood and Simon B. Sutcliffe

1 - The cancer challenge
1:Cancer control and the burden of cancer, M Elwood, S Sutcliffe
2 - Prevention and screening
2:Active cancer prevention, G Colditz, C Beers
3:Achieving behavioural changes in individuals and populations, D Hill, H Dixon
4:Early diagnosis and screening in cancer control, A Miller
3 - Applying new research
5:Integrating science with service in cancer control: closing the gap between discovery and delivery, J Kerner
6:The impact of immunization on cancer control: the example of HPV vaccination, A Burchell, E Franco
4 - Improving patient care
7:Improving cancer services: the approach taken in England, M Richards
8:Population-based cancer control and the role of guidelines - towards a 'systems' approach, GP Browman, M Brouwers, B Fervers, C Sawka
9:The optimal provision of cancer treatment services, M Barton, G Delaney
10:Managing the cost of new therapies: the challenge of funding new drugs, S O'Reilly, J Venkatesh
11:Community supports for people affected by cancer, M Jefford
12:Improving quality of life, S Bush, E Bruera
13:Shifting the paradigm: from complementary and alternative medicine (CAM) to integrative oncology, A Leis, S Sagar, M Verhoef, L Balneaves, D Seely, D Oneschuk
14:Patient centred supportive and palliative care, G Thompson, C Ens, H Chochinov
Part 5 - Integrated cancer control
15:From cancer care to cancer control: organization of population-based cancer control systems, S Sutcliffe
16:Getting the public involved in cancer control - doing something besides worrying, P Kelly, W Friedman, T Addis, M Elwood, C Neil, M Sarner, S Sutcliffe
17:Organizational structures for cancer control, L Caron
18:Evaluating the outcomes of cancer control, A Micheli, P Baili, R Ciampichini, A Verdecchia
19:Priority setting methods and cancer control, S Peacock, L Hedden, C Mitton
20:Ethics and the idea of cancer control, L Schwartz
21:Integrating cancer control with control of other non-communicable diseases, R Burton, J Leowski Jr, M de Courten
22:Cancer control in developing countries, I Magrath
23:Strengthening the global community for cancer control, S Sutcliffe, M Elwood

Cancer Control

Edited by J. Mark Elwood and Simon B. Sutcliffe

Author Information

Edited by J. Mark Elwood, Vice-President, Family and Community Oncology, British Columbia Cancer Agency, Vancouver, Canada, and Simon B. Sutcliffe, Chair, Canadian Partnership Against Cancer, Canada

Contributors:

Tara Addis, BSc. Chair, Stakeholder Relations, Campaign to Control Cancer (C2CC), Toronto, Canada
Paolo Baili, PhD. Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Lynda Balneaves, RN, PhD.Associate Professor and CIHR New Investigator, School of Nursing, University of British Columbia, Vancouver, British Columbia, Canada
Michael Barton, OAM, MBBS, MD, FRANZCR. Professor of Radiation Oncology, South West Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia
Courtney Beers, MPH. Alvin J. Siteman Cancer Center and Department of Surgery, Washington University School of Medicine, St. Louis, Missouri USA
Melissa Brouwers, PhD. McMaster University, Hamilton, and Cancer Care Ontario, Toronto, Canada
George P. Browman, MD. University of British Columbia, and BC Cancer Agency, Vancouver Island Cancer Centre, Victoria, British Columbia, Canada
Eduardo Bruera, MD. Palliative Care and Rehabilitation Medicine, The University of Texas M.D. Anderson Cancer Centre, Houston, Texas, USA
Ann N Burchell, PhD. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, Canada
Robert Burton, MD, PhD, FAFPHM. Professor, School of Public Health and Preventive Medicine, Monash University; Department of Epidemiology and Preventive Medicine, The Alfred Hospital, Melbourne, Victoria, Australia
Shirley H Bush, MB BS, MRCGP, FAChPM, Assistant Professor, Division of Palliative Care, University of Ottawa and Palliative Care Physician, The Ottawa Hospital and Bruyère Continuing Care, Ottawa, Ontario, Canada
Lorraine Caron, PhD. Consulting researcher, Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS), Montréal, Québec, Canada
Harvey M.Chochinov, MD, PhD, FRSC. Distinguished Professor and Canada Research Chair in Palliative Care, Department of Psychiatry, University of Manitoba; Director, Manitoba Palliative Care Research Unit, CancerCare Manitoba, Winnipeg, Manitoba, Canada
Roberta Ciampichini, PhD. Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Graham A. Colditz, MD. Alvin J. Siteman Cancer Center and Department of Surgery, Washington University School of Medicine, St. Louis, Missouri USA
Maximilian de Courten MD, MPH. Associate Professor of Clinical Epidemiology, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
Geoff Delaney, MBBS, MD, PhD, FRANZCR. Professor and Director of Radiation Oncology, Western Zone, Sydney South West Area Health Service, Liverpool, New South Wales, Australia
Helen Dixon, PhD. Senior Research Fellow, Centre for Behavioural Research in Cancer, Cancer Council Victoria, , Australia
J. Mark Elwood, MD, DSc, FRCPC, FAFPHM. Vice President, Family and Community Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada
Carla D.L. Ens, MSc. Department of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada
Béatrice Fervers, MD. Université de Lyon, Centre Léon Bérard, Lyon, France
Eduardo L. Franco, MD, DrPH. Professor of Epidemiology and Oncology; Director, Division of Cancer Epidemiology, McGill University, Montreal, Quebec, Canada
William Friedman, PhD. CEO and Director of Public Engagement, Public Agenda, New York, NY, USA
Lindsay Hedden, MSc. Research Scientist, National Centre for Health Economics, Services, Policy and Ethics in Cancer; Research Scientist, BC Cancer Agency, Vancouver, British Columbia, Canada
David J. Hill, AO, PhD. Director, Cancer Council Victoria, Australia; President (2008-10), International Union Against Cancer (UICC)
Michael Jefford, MB BS, PhD, FRACP. Clinical Consultant, The Cancer Council Victoria, Associate Professor of Medicine, University of Melbourne; Consultant medical oncologist, Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Patricia Kelly, MA. Chief Executive Officer, Campaign to Control Cancer (C2CC), Toronto, Ontario, Canada
Jon F. Kerner, PhD. Senior Scientific Advisor for Cancer Control and Knowledge Translation, Canadian Partnership Against Cancer, Toronto, Ontario Canada
Anne Leis, PhD. Professor and Dr. Louis Schulman Cancer Research Chair, Department of Community Health and Epidemiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Jerzy Leowski Jr, MD. Regional Adviser, Noncommunicable Diseases, World Health Organization, Regional Office for South-East Asia, New Dehli, India
Ian T. Magrath, MB BS, FRCP, FRCPath. President, International Network for Cancer Treatment and Research (INCTR), Brussels, Belgium
Andrea Micheli, PhD. Descriptive Studies and Health Planning Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Anthony B. Miller, MD, FRCP. Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
Craig Mitton, PhD. Assistant Professor, University of British Columbia, Okanagan, Kelowna, British Columbia, Canada
Claire Neal, MPH, CHES. Director of Education and Program Development, Lance Armstrong Foundation, Austin, Texas, USA
Doreen Oneschuk. MD, CCFP, Division of Palliative Care Medicine, Palliative Care Program, Grey Nuns Community Hospital, Edmonton, Alberta, Canada
Susan E. O'Reilly, MB, FRCPC. Vice President, Cancer Care, BC Cancer Agency, Vancouver, British Columbia, Canada
Stuart J. Peacock, DPhil. Co-Director, (Canadian) National Centre for Health Economics, Services, Policy and Ethics in Cancer; Senior Scientist, BC Cancer Agency; Assistant Professor, University of British Columbia, Vancouver, British Columbia, Canada
Mike Richards, CBE, MD, FRCP. National Cancer Director, England
Stephen Sagar, MBBS, MRCP, FRCR, FRCPC, DABR. Radiation oncologist, Juravinski Cancer Centre and Associate Professor, Departments of Oncology and Medicine, McMaster University, Hamilton, Ontario, Canada
Mark Sarner. President/CEO, Manifest Communications, Toronto, Ontario, Canada
Carol Sawka, MD. University of Toronto and Cancer Care Ontario, Toronto, Canada
Lisa Schwartz, PhD. Arnold L. Johnson Chair in Health Care Ethics; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada
Dugald Seely, ND, MSc. Research Director, Canadian College of Naturopathic Medicine, Toronto, Ontario, Canada
Simon B. Sutcliffe, MD, FRCP, FRCPC, FRCR. Board Chair, Canadian Partnership Against Cancer, Canada; past President, BC Cancer Agency, Vancouver, British Columbia, Canada
Genevieve N. Thompson, RN, PhD. Manitoba Palliative Care Research Unit, CancerCare Manitoba; Research Associate, Faculty of Nursing, University of Manitoba, Winnipeg, Manitoba, Canada
Jaya Venkatesh, MHA, CMA. Director, Business Strategy and Operations, BC Cancer Agency, Vancouver, British Columbia, Canada
Arduino Verdecchia, PhD, National Centre of Epidemiology, Health Surveillance and Promotion, Istituto Superiore di Sanità, Rome, Italy
Marja Verhoef, PhD, Professor and Canada Research Chair in Complementary Medicine, Department of Community Health Sciences, University of Calgary, Alberta, Canada

Cancer Control

Edited by J. Mark Elwood and Simon B. Sutcliffe

Reviews and Awards

"With the completion of this extremely ambitious endeavour, the editors have succeeded in producing a consoliated resource to understand and address the many important issues associated with cancer control." - Therese A. Dolecek, Doody's Notes